Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Sleep Aids market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
The Sleep Aids market in Southern Europe has been experiencing steady growth in recent years.
Customer preferences: Customers in Southern Europe have shown a growing interest in sleep aids due to the increasing awareness about the importance of sleep and its impact on overall health and well-being. Many people in the region have busy lifestyles and face high levels of stress, which can lead to sleep problems. As a result, there is a growing demand for sleep aids that can help improve sleep quality and promote relaxation.
Trends in the market: One of the key trends in the Sleep Aids market in Southern Europe is the rising popularity of natural and herbal sleep aids. Customers are increasingly seeking products that are made from natural ingredients and have minimal side effects. This trend is driven by a growing preference for holistic and alternative approaches to health and wellness. Manufacturers are responding to this trend by introducing a wide range of natural sleep aids that are derived from plants and herbs known for their calming and sleep-inducing properties. Another trend in the market is the increasing availability and variety of sleep aids in different formats. Customers in Southern Europe have a wide range of options to choose from, including pills, capsules, liquids, and even sleep-inducing teas. This variety allows customers to find a sleep aid that suits their preferences and needs.
Local special circumstances: Southern Europe is known for its rich culinary traditions and cultural practices. This has influenced the Sleep Aids market in the region, with customers showing a preference for sleep aids that are aligned with their cultural practices. For example, herbal teas infused with traditional Mediterranean herbs like chamomile and lavender are popular choices among customers in Southern Europe.
Underlying macroeconomic factors: The Sleep Aids market in Southern Europe is influenced by various macroeconomic factors. The region has been experiencing economic growth, which has led to an increase in disposable incomes. This has allowed customers to spend more on health and wellness products, including sleep aids. In addition, the aging population in Southern Europe is also driving the growth of the Sleep Aids market. As people age, they are more likely to experience sleep problems, such as insomnia. This has created a growing market for sleep aids targeted towards the elderly population. Overall, the Sleep Aids market in Southern Europe is witnessing growth due to the increasing awareness about the importance of sleep, the rising popularity of natural and herbal sleep aids, the availability of sleep aids in different formats, and the influence of local cultural practices. The region's economic growth and aging population are also contributing factors to the market's development.
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights